|
WO1987000196A1
(en)
|
1985-07-09 |
1987-01-15 |
Quadrant Bioresources Limited |
Protection of proteins and the like
|
|
US4958257A
(en)
|
1989-03-29 |
1990-09-18 |
Hughes Aircraft Company |
Heat conducting interface for electronic module
|
|
US5945098A
(en)
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
|
IL101007A
(en)
|
1992-02-18 |
1997-08-14 |
Pharmos Ltd |
Dry stable compositions prepared by lyophilization
|
|
ATE213162T1
(de)
*
|
1992-03-13 |
2002-02-15 |
Terry R Beardsley |
Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem
|
|
WO1994000481A1
(en)
|
1992-06-23 |
1994-01-06 |
Associated Synapse Biologics |
Pharmaceutical composition containing botulinum b complex
|
|
ES2159624T3
(es)
*
|
1993-12-28 |
2001-10-16 |
Allergan Sales Inc |
Toxinas botulinicas para el tratamiento de la hiperhidrosis.
|
|
EP1086702B1
(en)
|
1994-05-09 |
2005-04-13 |
BINDER, William J. |
Presynaptic neurotoxins for treatment of migraine headache
|
|
US6203794B1
(en)
|
1994-05-31 |
2001-03-20 |
Allergan Sales, Inc. |
Modification of clostridial toxins for use as transport proteins
|
|
US5962637A
(en)
|
1994-06-03 |
1999-10-05 |
Microbiological Research Authority |
Toxin assay
|
|
GB9411138D0
(en)
|
1994-06-03 |
1994-07-27 |
Microbiological Res Authority |
Toxin assay
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US5756468A
(en)
|
1994-10-13 |
1998-05-26 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
|
|
US5512547A
(en)
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
US5556771A
(en)
|
1995-02-10 |
1996-09-17 |
Gen-Probe Incorporated |
Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
|
|
GB9508204D0
(en)
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
|
DE69627963T2
(de)
|
1995-06-06 |
2004-03-04 |
Pearce, L. Bruce, Cambridge |
Verbesserte zusammensetzungen und verfahren zur chemodenervation mit neurotoxinen
|
|
AU4746096A
(en)
|
1995-06-06 |
1996-12-24 |
Wisconsin Alumni Research Foundation |
Analogs of botulinum toxin and pharmaceutical compositions o f botulinum toxin
|
|
GB9617671D0
(en)
|
1996-08-23 |
1996-10-02 |
Microbiological Res Authority |
Recombinant toxin fragments
|
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
TW518235B
(en)
|
1997-01-15 |
2003-01-21 |
Akzo Nobel Nv |
A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
|
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
|
US9066943B2
(en)
|
1997-07-15 |
2015-06-30 |
The Regents Of The University Of Colorado |
Use of botulinum toxin therapy for treatment of urological neurological conditions
|
|
EP1658858B2
(en)
|
1997-07-15 |
2014-03-26 |
The Regents of the University of Colorado |
Use of botulinum toxin for the treatment of recalcitrant voiding dysfunction
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
CN1073626C
(zh)
|
1997-10-18 |
2001-10-24 |
卫生部兰州生物制品研究所 |
A型肉毒结晶毒素的生产工艺及生产该毒素所需的冻干保护液
|
|
SE510813C2
(sv)
|
1997-12-08 |
1999-06-28 |
Arla Ekonomisk Foerening |
Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
|
|
GB9818548D0
(en)
|
1998-08-25 |
1998-10-21 |
Microbiological Res Authority |
Treatment of mucas hypersecretion
|
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
|
US20050147690A1
(en)
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
|
SI1031346T1
(en)
|
1999-01-27 |
2002-08-31 |
Idea Ag |
Noninvasive vaccination through the skin
|
|
ES2173679T3
(es)
|
1999-01-27 |
2002-10-16 |
Idea Ag |
Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
|
|
US6776990B2
(en)
|
1999-04-08 |
2004-08-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pancreatitis
|
|
US6573244B1
(en)
|
1999-05-17 |
2003-06-03 |
The United States Of America As Represented By The Secretary Of The Army |
Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
|
|
DE19925739A1
(de)
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US6977080B1
(en)
|
1999-08-10 |
2005-12-20 |
Allergan, Inc. |
Intrapericardial botulinum toxin treatment for bradycardia
|
|
HK1046020B
(en)
|
1999-08-25 |
2007-05-11 |
Allergan, Inc. |
Activatable recombinant neurotoxins
|
|
US20030180289A1
(en)
|
1999-09-23 |
2003-09-25 |
Foster Keith Alan |
Inhibition of secretion from non-neuronal cells
|
|
US6534064B1
(en)
|
1999-10-13 |
2003-03-18 |
Chiron Corporation |
Stabilized protein particles for inducing cellular immune responses
|
|
IL149778A0
(en)
|
1999-11-22 |
2002-11-10 |
Universal Preservation Technologies Inc |
Preservation of sensitive biological material
|
|
US6500436B2
(en)
|
2000-01-19 |
2002-12-31 |
Allergan, Inc. |
Clostridial toxin derivatives and methods for treating pain
|
|
US20030118598A1
(en)
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US20030138460A1
(en)
|
2000-02-08 |
2003-07-24 |
Allergan, Inc |
Methods of treating animals with botulinum toxin pharmaceutical compositions
|
|
US20060269575A1
(en)
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
EP1586329A1
(en)
|
2000-02-08 |
2005-10-19 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions
|
|
US8632785B2
(en)
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
|
US20040033241A1
(en)
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US7491799B2
(en)
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
US6653062B1
(en)
|
2000-07-26 |
2003-11-25 |
Wisconsin Alumni Research Foundation |
Preservation and storage medium for biological materials
|
|
US6630330B1
(en)
|
2000-08-02 |
2003-10-07 |
Biopolo S.C.A.R.L. |
Ascorbic acid production from yeast
|
|
UA78689C2
(en)
|
2000-10-31 |
2007-04-25 |
Boehringer Ingelheim Pharma |
Pyranone-based pharmaceutical composition (variants)
|
|
US7223577B2
(en)
|
2000-11-17 |
2007-05-29 |
Allergan, Inc. |
Post-translational modifications and Clostridial neurotoxins
|
|
US7273722B2
(en)
|
2000-11-29 |
2007-09-25 |
Allergan, Inc. |
Neurotoxins with enhanced target specificity
|
|
US7255865B2
(en)
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
ITUD20010002A1
(it)
|
2001-01-05 |
2002-07-05 |
Univ Degli Studi Udine |
Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo
|
|
US7442686B2
(en)
|
2001-04-12 |
2008-10-28 |
Bioaxone Therapeutique Inc. |
Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
|
|
US20060134140A1
(en)
|
2001-04-12 |
2006-06-22 |
Dana Lasko |
Compositions and methods for treating tumor spreading
|
|
CN1512890A
(zh)
|
2001-04-25 |
2004-07-14 |
开米卡公司 |
Hcg制剂
|
|
US9157875B2
(en)
|
2001-05-16 |
2015-10-13 |
Benjamin P. Warner |
Drug development and manufacturing
|
|
US7332567B2
(en)
|
2001-08-28 |
2008-02-19 |
Allergan, Inc. |
Fret protease assays for clostridial toxins
|
|
US7208285B2
(en)
|
2001-08-28 |
2007-04-24 |
Allergan, Inc. |
Fret protease assays for botulinum serotype A/E toxins
|
|
US8022172B2
(en)
|
2001-08-28 |
2011-09-20 |
Allergan, Inc. |
Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
|
|
US20030104996A1
(en)
|
2001-08-30 |
2003-06-05 |
Tiansheng Li |
L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
MXPA01011542A
(es)
|
2001-11-13 |
2003-05-22 |
Alcon Inc |
Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
|
|
US7691394B2
(en)
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7183066B2
(en)
|
2002-09-27 |
2007-02-27 |
Allergan, Inc. |
Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
|
|
WO2004033668A2
(en)
|
2002-10-10 |
2004-04-22 |
Diversa Corporation |
Proteases, nucleic acids encoding them and methods for making and using them
|
|
AU2003279493B2
(en)
|
2002-10-25 |
2009-08-20 |
Foamix Pharmaceuticals Ltd. |
Cosmetic and pharmaceutical foam
|
|
US20040086532A1
(en)
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
US20040143213A1
(en)
|
2002-11-12 |
2004-07-22 |
Collegium Pharmaceutical, Inc. |
Inertial drug delivery system
|
|
US20060074014A1
(en)
|
2002-11-18 |
2006-04-06 |
Vicuron Pharmaceuticals Inc. |
Dalbavancin compositions for treatment of bacterial infections
|
|
US20060002862A1
(en)
|
2002-12-17 |
2006-01-05 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
DE60326887D1
(de)
|
2002-12-20 |
2009-05-07 |
Botulinum Toxin Res Ass Inc |
Pharmazeutische zusammensetzungen enthaltend botulinumtoxin und humanes serum-albumin
|
|
GB0300427D0
(en)
|
2003-01-09 |
2003-02-05 |
Univ Strathclyde |
Pharmaceutical composition
|
|
US7601740B2
(en)
|
2003-01-16 |
2009-10-13 |
Acadia Pharmaceuticals, Inc. |
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
|
|
US7758872B1
(en)
|
2003-02-07 |
2010-07-20 |
Eric Finzi |
Method of treating depression
|
|
EP1599213A4
(en)
|
2003-02-24 |
2009-07-15 |
Ira Sanders |
CELL MEMBRANE TRANSLOCATION OF SNARE R GUL S INHIBITORS, ASSOCIATED COMPOSITIONS AND PATHOLOGY TREATMENT PROCESSES
|
|
AU2004218354B2
(en)
|
2003-03-05 |
2009-10-01 |
Halozyme, Inc. |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20040204471A1
(en)
|
2003-03-20 |
2004-10-14 |
Pharmacia Corporation |
Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents
|
|
US20040214753A1
(en)
|
2003-03-20 |
2004-10-28 |
Britten Nancy Jean |
Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
|
|
EP1610808A4
(en)
|
2003-03-26 |
2011-04-06 |
Sudhir Paul |
COVALENT BINDING OF LIGANDS TO NUCLEOPHILIC PROTEINS UNDER GUIDANCE BY NONCOVALENT BINDING
|
|
WO2005030119A2
(en)
|
2003-04-11 |
2005-04-07 |
Allergan, Inc. |
Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
|
US7396535B2
(en)
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
|
US7393537B2
(en)
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
|
CA2530954A1
(en)
|
2003-07-02 |
2005-01-13 |
Alza Corporation |
Microprojection array immunization patch and method
|
|
DE10333317A1
(de)
|
2003-07-22 |
2005-02-17 |
Biotecon Therapeutics Gmbh |
Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
|
|
US20050042775A1
(en)
|
2003-08-21 |
2005-02-24 |
Nicholas Pomato |
Botulinum antitoxin compositions and methods
|
|
WO2005034852A2
(en)
|
2003-08-26 |
2005-04-21 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
|
US7148041B2
(en)
|
2003-09-25 |
2006-12-12 |
Allergan, Inc. |
Animal product free media and processes for obtaining a botulinum toxin
|
|
US7160699B2
(en)
|
2003-09-25 |
2007-01-09 |
Allergan, Inc. |
Media for clostridium bacterium and processes for obtaining a clostridial toxin
|
|
US8734810B2
(en)
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
|
US8609112B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US20050123565A1
(en)
|
2003-10-31 |
2005-06-09 |
Janardhanan Subramony |
System and method for transdermal vaccine delivery
|
|
AU2004292953A1
(en)
|
2003-11-21 |
2005-06-09 |
Alza Corporation |
Ultrasound assisted transdermal vaccine delivery method and system
|
|
GB0328060D0
(en)
|
2003-12-04 |
2004-01-07 |
Sod Conseils Rech Applic |
Botulinum toxin treatment
|
|
WO2005055945A2
(en)
|
2003-12-08 |
2005-06-23 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
|
EP2492261B1
(en)
|
2003-12-23 |
2015-02-18 |
Infinity Discovery, Inc. |
Analogs of benzoquinone-containing ansamycins for the treatment of cancer
|
|
BRPI0417757A
(pt)
|
2004-01-09 |
2007-04-10 |
Alza Corp |
método e sistema de liberação de agente transdérmico assistida por freqüência
|
|
FR2865131B1
(fr)
|
2004-01-15 |
2007-08-24 |
Gattefosse Ets Sa |
Utilisation d'un extrait d'acmella oleracea pour son effet botox like dans une composition cosmetique anti-rides
|
|
DK1718756T3
(da)
|
2004-02-24 |
2012-02-27 |
Allergan Inc |
Botulinumtoksinscreeningassays
|
|
US9078892B2
(en)
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
|
US20050191321A1
(en)
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
|
KR101330775B1
(ko)
|
2004-03-03 |
2013-11-18 |
레반스 테라퓨틱스, 아이엔씨. |
보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US7674454B2
(en)
|
2004-03-06 |
2010-03-09 |
Innovata Limited |
Enzyme-prodrug therapy for prosthetic joint repair
|
|
US20050214325A1
(en)
|
2004-03-26 |
2005-09-29 |
Vvii Newco 2003, Inc. |
Compositions and methods to increase the effect of a neurotoxin treatment
|
|
CA2562932A1
(en)
|
2004-04-01 |
2005-10-27 |
Alza Corporation |
Apparatus and method for transdermal delivery of influenza vaccine
|
|
WO2005098009A2
(en)
|
2004-04-09 |
2005-10-20 |
Wyeth |
Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
|
|
US20050271684A1
(en)
|
2004-04-13 |
2005-12-08 |
Trautman Joseph C |
Apparatus and method for transdermal delivery of multiple vaccines
|
|
CA2565678C
(fr)
|
2004-05-05 |
2013-07-09 |
Pharmaleads |
Substrats peptidiques reconnus par la toxine botulique de type a, bont/a et leurs utilisations
|
|
US7591806B2
(en)
|
2004-05-18 |
2009-09-22 |
Bai Xu |
High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
|
|
WO2005112463A2
(en)
|
2004-05-19 |
2005-11-24 |
Alza Corporation |
Method and formulation for transdermal delivery of immunologically active agents
|
|
DE102004026152A1
(de)
|
2004-05-28 |
2005-12-15 |
Basf Ag |
Fermentative Herstellung von Feinchemikalien
|
|
US9750797B2
(en)
|
2004-06-16 |
2017-09-05 |
Virbac Corporation |
Sustained release vaccine composition
|
|
AU2005256322C1
(en)
|
2004-06-28 |
2011-07-07 |
Veloxis Pharmaceuticals, Inc. |
Porous tablets as carriers for liquid formulations
|
|
WO2006011966A1
(en)
|
2004-06-30 |
2006-02-02 |
Allergan, Inc. |
Optimizing expression of active botulinum toxin type e
|
|
US7514088B2
(en)
|
2005-03-15 |
2009-04-07 |
Allergan, Inc. |
Multivalent Clostridial toxin derivatives and methods of their use
|
|
US20060004185A1
(en)
|
2004-07-01 |
2006-01-05 |
Leese Richard A |
Peptide antibiotics and peptide intermediates for their prepartion
|
|
GB2416122A
(en)
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
US7879341B2
(en)
|
2004-07-26 |
2011-02-01 |
Merz Pharma Gmbh & Co. Kgaa |
Therapeutic composition with a botulinum neurotoxin
|
|
DK1776137T3
(en)
|
2004-08-04 |
2015-01-05 |
Ipsen Biopharm Ltd |
A pharmaceutical composition comprising botulinum neurotoxin A2
|
|
EP1773874B1
(en)
|
2004-08-04 |
2012-10-24 |
Allergan, Inc. |
Optimizing expression of active botulinum toxin type a
|
|
GB2419527A
(en)
|
2004-10-28 |
2006-05-03 |
Ipsen Ltd |
Pharmaceutical composition containing botulinum neurotoxin
|
|
EP1982997B1
(en)
|
2004-09-01 |
2012-08-08 |
Allergan, Inc. |
Degradable clostridial toxins
|
|
ES2572811T3
(es)
|
2004-09-09 |
2016-06-02 |
Yeda Research And Development Co., Ltd. |
Mezclas de polipéptidos, composiciones que las contienen y procedimientos para obtener los mismos, y usos de los mismos
|
|
CA2518650A1
(en)
|
2004-09-10 |
2006-03-10 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
|
US7399607B2
(en)
|
2004-09-22 |
2008-07-15 |
Allergan, Inc. |
Fluorescence polarization assays for determining clostridial toxin activity
|
|
CN101890167B
(zh)
|
2004-10-01 |
2017-03-01 |
拉姆斯科股份有限公司 |
可方便植入的缓释药物组合物
|
|
US20070258992A1
(en)
|
2004-10-06 |
2007-11-08 |
Atassi M Zouhair |
Determining and Reducing Immunoresistance to Botulinum Toxin Therapy Using Botulinum Toxin a Peptides
|
|
US7205018B2
(en)
|
2004-10-07 |
2007-04-17 |
Next Proteins, Inc. |
Carbonated protein drink and method of making
|
|
WO2006047870A1
(en)
|
2004-11-02 |
2006-05-11 |
Gangagen Life Sciences Inc. |
Stabilized bacteriophage formulations
|
|
US9504658B2
(en)
|
2004-11-09 |
2016-11-29 |
Board Of Regents, The University Of Texas System |
Stabilized HME composition with small drug particles
|
|
WO2006059105A2
(en)
|
2004-12-01 |
2006-06-08 |
Health Protection Agency |
Non-cytotoxic Protein Conjugates
|
|
GB0426394D0
(en)
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
EP1830872B1
(en)
|
2004-12-01 |
2010-11-17 |
Health Protection Agency |
Fusion proteins
|
|
US8192979B2
(en)
|
2005-01-03 |
2012-06-05 |
Botulinum Toxin Research Associates, Inc. |
Compositions, methods and devices for preparing less painful Botulinum toxin formulations
|
|
US20080220021A1
(en)
|
2005-02-14 |
2008-09-11 |
Pankaj Modi |
Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
|
|
US7727537B2
(en)
|
2005-02-14 |
2010-06-01 |
Dpm Therapeutics Corp. |
Stabilized compositions for topical administration and methods of making same
|
|
US7838011B2
(en)
|
2005-02-14 |
2010-11-23 |
Pankaj Modi |
Stabilized protein compositions for topical administration and methods of making same
|
|
ZA200707352B
(en)
|
2005-03-03 |
2009-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
AU2005327458B2
(en)
|
2005-03-03 |
2011-12-15 |
Allergan, Inc. |
Animal product free system and process for purifying a botulinum toxin
|
|
CA2601592A1
(en)
|
2005-03-15 |
2006-09-28 |
Allergan, Inc. |
Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
|
|
WO2006106823A1
(ja)
|
2005-03-31 |
2006-10-12 |
Japan Science And Technology Agency |
分子マーカーを用いた間葉系幹細胞の識別方法及びその利用
|
|
US8124357B2
(en)
|
2005-04-05 |
2012-02-28 |
Allergan, Inc. |
Lipophilic dye-based fret assays for clostridal toxin activity
|
|
US20070029252A1
(en)
|
2005-04-12 |
2007-02-08 |
Dunson James B Jr |
System and process for biomass treatment
|
|
WO2006122123A2
(en)
|
2005-05-09 |
2006-11-16 |
Levin Bruce H |
Methods of alleviating disorders and their associated pain
|
|
US8926991B2
(en)
|
2005-06-14 |
2015-01-06 |
Botulinum Toxin Research Associates, Inc. |
Botulinum toxin and the treatment of primary disorders of mood and affect
|
|
US9486515B2
(en)
|
2005-06-27 |
2016-11-08 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
EP1951200A2
(en)
|
2005-08-09 |
2008-08-06 |
Nanobio Corporation |
Nanoemulsion compositions having anti-inflammatory activity
|
|
EP1954308B1
(en)
|
2005-09-16 |
2011-09-07 |
Merial Ltd. |
Stabilizers for freeze-dried vaccines
|
|
EP2377881B1
(en)
|
2005-09-19 |
2017-04-26 |
Allergan, Inc. |
Clostridial toxin activatable clostridial toxins
|
|
AU2013202329B2
(en)
*
|
2005-10-06 |
2016-04-14 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
CN101175478A
(zh)
*
|
2005-10-06 |
2008-05-07 |
阿勒根公司 |
非蛋白稳定的梭菌毒素药物组合物
|
|
US8168206B1
(en)
|
2005-10-06 |
2012-05-01 |
Allergan, Inc. |
Animal protein-free pharmaceutical compositions
|
|
US8137677B2
(en)
*
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
US20090324647A1
(en)
|
2005-10-11 |
2009-12-31 |
Borodic Gary E |
Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
|
|
DE102005051789B4
(de)
|
2005-10-28 |
2014-08-07 |
Toxogen Gmbh |
Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
CA2630597A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Effects of inhibitors of fgfr3 on gene transcription
|
|
WO2007077551A2
(en)
|
2005-12-30 |
2007-07-12 |
Mor Research Applications Ltd. |
Device and method for treating the anal sphincter
|
|
AU2007204755A1
(en)
|
2006-01-10 |
2007-07-19 |
Eugene J. Van Scott |
N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
|
|
KR20150001844A
(ko)
|
2006-01-24 |
2015-01-06 |
넥스바이오, 인코퍼레이티드 |
고분자 미소 구체들의 조제를 위한 기술
|
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
|
EP2105500A1
(de)
|
2008-03-26 |
2009-09-30 |
Pharmazell GmbH |
Neue 12alpha-Hydroxysteroiddehydrogenasen, deren Herstellung und deren Verwendung
|
|
US7473559B2
(en)
|
2006-04-05 |
2009-01-06 |
Charles Lee |
Method for measuring the content of a botulinum toxin in a formulation
|
|
US7309602B2
(en)
|
2006-04-13 |
2007-12-18 |
Ambrozea, Inc. |
Compositions and methods for producing fermentation products and residuals
|
|
ITTO20060282A1
(it)
|
2006-04-14 |
2007-10-15 |
Univ Degli Studi Torino |
Mezzo di coltura e composizione farmaceutica per la rigenerazione del tessuto cartilagineo relativo procedimento relativi usi e prodotti
|
|
AU2007347781B2
(en)
|
2006-07-11 |
2013-10-03 |
Allergan, Inc. |
Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity
|
|
AU2007272515B2
(en)
|
2006-07-11 |
2013-09-26 |
Allergan, Inc. |
Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells
|
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
|
TW200824678A
(en)
|
2006-08-11 |
2008-06-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
US9061025B2
(en)
|
2006-08-31 |
2015-06-23 |
Allergan, Inc. |
Methods for selecting headache patients responsive to botulinum toxin therapy
|
|
US8043845B2
(en)
|
2006-09-20 |
2011-10-25 |
American Sterilizer Company |
Sterilization indicator
|
|
WO2008127291A2
(en)
|
2006-10-10 |
2008-10-23 |
Los Alamos National Security, Llc |
Advanced drug development and manufacturing
|
|
EP1917971A1
(en)
|
2006-10-27 |
2008-05-07 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Substained release formulations comprising very low molecular weight polymers
|
|
EP1921149A1
(en)
|
2006-11-13 |
2008-05-14 |
AEterna Zentaris GmbH |
Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
|
|
WO2008070538A2
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Micellar nanoparticles comprising botulinum toxin
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
GB0700523D0
(en)
|
2007-01-11 |
2007-02-21 |
Insense Ltd |
The Stabilisation Of Proteins
|
|
DK2829282T3
(en)
|
2007-03-22 |
2018-01-02 |
Univ Colorado Regents |
Process for preparing an immunologically active adjuvant-linked dried vaccine composition
|
|
WO2008133884A2
(en)
|
2007-04-23 |
2008-11-06 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
EP1985276A1
(en)
|
2007-04-26 |
2008-10-29 |
Merz Pharma GmbH & Co. KGaA |
Treatment of movement disorders by a combined use of a chemodenervating agent and automated movement therapy
|
|
RU2440825C2
(ru)
|
2007-07-10 |
2012-01-27 |
Меди-Токс, Инк. |
Жидкая фармацевтическая композиция ботулинического токсина
|
|
AU2008299885C1
(en)
|
2007-09-14 |
2015-06-25 |
Sanofi Pasteur Biologics, Llc |
Pharmaceutical compositions containing clostridium difficile toxoids A and B
|
|
US8486467B1
(en)
|
2007-09-20 |
2013-07-16 |
Albert G. Prescott |
Dermal filler and method of using same
|
|
EP3424525A1
(en)
|
2007-10-12 |
2019-01-09 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
NZ622583A
(en)
|
2007-11-30 |
2015-08-28 |
Abbvie Biotechnology Ltd |
Protein formulations and methods of making same
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
CA2706894A1
(en)
|
2007-11-30 |
2009-06-11 |
The Regents Of The University Of California |
Biological systems for production of commercially valuable compounds
|
|
US9044477B2
(en)
|
2007-12-12 |
2015-06-02 |
Allergan, Inc. |
Botulinum toxin formulation
|
|
US9161970B2
(en)
|
2007-12-12 |
2015-10-20 |
Allergan, Inc. |
Dermal filler
|
|
JP2011510059A
(ja)
|
2008-01-25 |
2011-03-31 |
ビー アンド ティー エッセ．エッレ．エッレ． |
化粧品分野におけるエステル交換オリーブ油の使用
|
|
CA2710534C
(en)
|
2008-01-31 |
2018-09-04 |
Curevac Gmbh |
Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
|
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
|
KR101604515B1
(ko)
|
2008-03-14 |
2016-03-17 |
알러간, 인코포레이티드 |
면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
|
|
WO2009114748A1
(en)
|
2008-03-14 |
2009-09-17 |
Allergan, Inc. |
Immuno-based botulinum toxin serotype a activity assays
|
|
US9233080B2
(en)
|
2008-03-27 |
2016-01-12 |
Agigma, Inc. |
Compositions and methods for the delivery of agents
|
|
US8617571B2
(en)
|
2008-04-03 |
2013-12-31 |
Allergan, Inc. |
Suture line administration technique using botulinum toxin
|
|
US9119866B2
(en)
|
2008-04-08 |
2015-09-01 |
Huiru Wang |
Glycan-based drugs, therapies and biomarkers
|
|
KR101100866B1
(ko)
|
2008-04-14 |
2012-01-02 |
한국과학기술원 |
게놈 수준에서의 부탄올 생산 미생물의 대사 네트워크 모델 및 이를 이용한 부탄올 생성 미생물의 대사특성분석 및 결실 표적 스크리닝 방법
|
|
RU2636399C1
(ru)
|
2008-04-30 |
2017-11-23 |
Ксилеко, Инк. |
Переработка биомассы
|
|
KR20090120222A
(ko)
|
2008-05-19 |
2009-11-24 |
(주)메디톡스 |
식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
|
|
CA2725329C
(en)
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
US20110212157A1
(en)
|
2008-06-26 |
2011-09-01 |
Anterios, Inc. |
Dermal delivery
|
|
WO2010011597A2
(en)
|
2008-07-22 |
2010-01-28 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
EP2998402A1
(en)
|
2008-10-17 |
2016-03-23 |
Joule Unlimited Technologies, Inc. |
Ethanol production by microorganisms
|
|
US9072688B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
|
DK2355851T3
(en)
|
2008-11-10 |
2018-06-25 |
Arbutus Biopharma Corp |
Newly known lipids and compositions for release of therapeutic agents
|
|
CA2745657C
(en)
|
2008-12-04 |
2022-06-21 |
Botulinum Toxin Research Associates, Inc. |
Extended length botulinum toxin formulation for human or mammalian use
|
|
AU2009339292B2
(en)
*
|
2008-12-10 |
2016-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
WO2010066203A1
(en)
|
2008-12-10 |
2010-06-17 |
Anhui Zhongren Technology Co., Ltd. |
Controlled releasing composition
|
|
WO2010071817A2
(en)
|
2008-12-19 |
2010-06-24 |
Momenta Pharmaceuticals, Inc. |
Characterization of o-linked glycans
|
|
WO2010078242A1
(en)
|
2008-12-31 |
2010-07-08 |
Revance Therapeutics, Inc. |
Injectable botulinum toxin formulations
|
|
CN104887389B
(zh)
|
2009-01-29 |
2017-06-23 |
弗赛特影像4股份有限公司 |
后段给药
|
|
US9744237B2
(en)
|
2009-01-29 |
2017-08-29 |
Kambiz Thomas Moazed |
Method and system for effecting changes in pigmented tissue
|
|
KR101806567B1
(ko)
|
2009-02-19 |
2018-01-10 |
메르츠 파마 게엠베하 운트 코. 카가아 |
매우 순수한 신경독을 제조하기 위한 수단 및 방법
|
|
BRPI1008940A2
(pt)
|
2009-03-13 |
2020-10-27 |
Allergan, Inc. |
linhagem de célula clonal estabelecida suscetível à intoxicação por bont/a
|
|
SI3281953T1
(sl)
|
2009-03-13 |
2020-03-31 |
Allergan, Inc. |
Na imunosti temelječi testi za aktivnosti ponovno ciljane endopeptidaze
|
|
DK2413947T3
(da)
|
2009-04-01 |
2020-06-02 |
Revance Therapeutics Inc |
Fremgangsmåder og sammensætninger til behandling af hudtilstande forbundet med vaskulær hyperreaktivitet
|
|
EP2248518B1
(en)
|
2009-04-17 |
2013-01-16 |
Merz Pharma GmbH & Co. KGaA |
Formulation for stabilizing proteins, peptides or mixtures thereof.
|
|
ES2613604T3
(es)
|
2009-04-24 |
2017-05-24 |
Nestec S.A. |
Fermentos lácteos fermentados, estables a la conservación, y procedimientos para la elaboración de los mismos
|
|
US20180027833A1
(en)
|
2009-04-24 |
2018-02-01 |
Nestec S.A. |
Shelf-stable fermented dairy products and methods of making same
|
|
US9539233B2
(en)
|
2009-05-04 |
2017-01-10 |
Aridis Pharmaceuticals Inc. |
Gallium formulation for the treatment and prevention of infectious diseases
|
|
CA2760776C
(en)
|
2009-05-05 |
2019-07-09 |
Alnylam Pharmaceuticals, Inc. |
Lipid compositions for the delivery of therapeutic agents
|
|
US9545360B2
(en)
|
2009-05-13 |
2017-01-17 |
Sio2 Medical Products, Inc. |
Saccharide protective coating for pharmaceutical package
|
|
CA2764609C
(en)
|
2009-06-10 |
2018-10-02 |
Alnylam Pharmaceuticals, Inc. |
Improved cationic lipid of formula i
|
|
EP2445481B1
(en)
|
2009-06-18 |
2017-03-22 |
Rdd Pharma Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
|
JP5792718B2
(ja)
|
2009-06-24 |
2015-10-14 |
ソパーカー、チャールズ エヌ．エス．ＳＯＰＡＲＫＡＲ，Ｃｈａｒｌｅｓ Ｎ．Ｓ． |
処置前治療用メタロプロテアーゼ準備パック
|
|
SG177357A1
(en)
*
|
2009-06-25 |
2012-02-28 |
Revance Therapeutics Inc |
Albumin-free botulinum toxin formulations
|
|
CN102470096B
(zh)
|
2009-06-30 |
2013-12-18 |
株式会社爱茉莉太平洋 |
一种含有覆盆子提取物的改善皮肤皱纹用化妆品组合物
|
|
US9458536B2
(en)
|
2009-07-02 |
2016-10-04 |
Sio2 Medical Products, Inc. |
PECVD coating methods for capped syringes, cartridges and other articles
|
|
US8129139B2
(en)
|
2009-07-13 |
2012-03-06 |
Allergan, Inc. |
Process for obtaining botulinum neurotoxin
|
|
CN102625844A
(zh)
|
2009-07-24 |
2012-08-01 |
加州大学评议会 |
用于改善糖转运、混合的糖发酵和生物燃料的制备的方法和组合物
|
|
EP2464341B1
(en)
|
2009-08-12 |
2022-07-06 |
Sublimity Therapeutics Limited |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
|
WO2011028962A1
(en)
|
2009-09-04 |
2011-03-10 |
Xoma Technology Ltd. |
Antibody coformulations
|
|
US8821879B2
(en)
|
2009-09-04 |
2014-09-02 |
Xoma Technology Ltd. |
Anti-botulism antibody coformulations
|
|
BR112012005763B1
(pt)
|
2009-09-14 |
2020-06-09 |
Changhae Ethanol Co Ltd |
método de preparação para materiais bio-combustíveis
|
|
EP2513321A2
(en)
|
2009-12-15 |
2012-10-24 |
Stratley AG |
Method for recovery of organic components from dilute aqueous solutions
|
|
CN102933200B
(zh)
|
2009-12-18 |
2015-11-25 |
莱迪杜德制药公司 |
包含磷脂的单相凝胶组合物
|
|
DK2525777T3
(da)
|
2010-01-20 |
2019-07-01 |
Urogen Pharma Ltd |
Materiale og fremgangsmåde til at behandle interne hulrum
|
|
US10471150B2
(en)
|
2010-01-20 |
2019-11-12 |
Urogen Pharma Ltd. |
Material and method for treating internal cavities
|
|
US8916162B2
(en)
|
2010-02-20 |
2014-12-23 |
Alexey Gennadievich Zdanovsky |
Botulinum neurotoxin antigenic compositions and methods
|
|
GB201004072D0
(en)
|
2010-03-11 |
2010-04-28 |
Turzi Antoine |
Process, tube and device for the preparation of wound healant composition
|
|
US9327105B2
(en)
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
US8940308B2
(en)
|
2010-03-30 |
2015-01-27 |
Allergan, Inc. |
Methods for treating depression
|
|
WO2011150258A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
BRPI1002601E2
(pt)
|
2010-06-01 |
2020-06-30 |
Embrapa Pesquisa Agropecuaria |
composição nanoestruturada de uso veterinário para administração de fármacos
|
|
KR101209266B1
(ko)
|
2010-06-30 |
2012-12-06 |
한국과학기술연구원 |
생분해성 및 온도 감응성 폴리포스파젠계 자성 고분자, 그의 제조 방법 및 용도
|
|
US9580461B2
(en)
|
2010-07-30 |
2017-02-28 |
Medimmune, Llc |
Method for purifying active polypeptides or immunoconjugates
|
|
ES2639617T3
(es)
|
2010-10-12 |
2017-10-27 |
Merz Pharma Gmbh & Co. Kgaa |
Formulación adecuada para estabilizar proteínas, que carece de excipientes de mamíferos
|
|
US8685381B2
(en)
|
2010-10-23 |
2014-04-01 |
Joel Schlessinger |
Topical base and active agent-containing compositions, and methods for improving and treating skin
|
|
KR20130113476A
(ko)
|
2010-10-27 |
2013-10-15 |
?티백트 에이/에스 |
인터칼레이터 （ｉｎｔｅｒｃａｌａｔｏｒ） 분자를 포함하는 프로브에 의한 표적 ＤＮＡ 및 ＲＮＡ의 캡쳐
|
|
JP2013544516A
(ja)
|
2010-11-03 |
2013-12-19 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
タンパク質性バイオマスの発酵を介した組換え微生物によるバイオ燃料および化学物質の生成
|
|
FR2967913A1
(fr)
|
2010-11-29 |
2012-06-01 |
Vetalis |
Composition galenique adaptee a l'administration a un animal non-humain, utilisations de celle-ci et methodes associees
|
|
EP2661276B1
(en)
|
2011-01-07 |
2017-08-02 |
Revance Therapeutics, Inc. |
Topical composition comprising botulinum toxin and a dye
|
|
KR20140005998A
(ko)
|
2011-01-24 |
2014-01-15 |
안테리오스, 인코퍼레이티드 |
나노입자 조성물, 이의 제형, 및 그의 용도
|
|
EP2675474B1
(en)
|
2011-02-15 |
2019-01-16 |
Vaxiion Therapeutics, LLC |
Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
|
|
CA2827956C
(en)
|
2011-02-23 |
2019-05-07 |
Ams Research Corporation |
Drug releasing pelvic treatment system and method
|
|
US20120222979A1
(en)
|
2011-03-04 |
2012-09-06 |
Elwha LLC, a limited liability company of the State of Delaware |
Glassy compositions
|
|
MX342675B
(es)
|
2011-03-10 |
2016-10-07 |
Xeris Pharmaceuticals Inc |
Formulaciones estables para inyeccion parenteral de farmacos de peptido.
|
|
DK3241547T3
(da)
*
|
2011-03-31 |
2020-08-17 |
Medy-Tox Inc |
Lyofiliseret præparat af botulinumtoksin
|
|
US20140030241A1
(en)
|
2011-03-31 |
2014-01-30 |
Nestec S.A. |
Nutritional compositions for increasing arginine levels and methods of using same
|
|
WO2012137201A1
(en)
|
2011-04-07 |
2012-10-11 |
Hcl Cleantech Ltd. |
Lignocellulose conversion processes and products
|
|
AU2012241815A1
(en)
|
2011-04-12 |
2013-09-26 |
Nestec S.A. |
Nutritional compositions including branched chain fatty acids and methods of using same
|
|
JP2014512372A
(ja)
|
2011-04-18 |
2014-05-22 |
ネステク ソシエテ アノニム |
α−ＨＩＣＡ及びエイコサペンタエン酸を含有する栄養組成物
|
|
SMT201900500T1
(it)
|
2011-05-08 |
2019-11-13 |
Legochem Biosciences Inc |
Coniugati di agente protettivo-proteina e metodo per preparare i medesimi
|
|
US20130309273A1
(en)
|
2012-05-17 |
2013-11-21 |
Kimberly Hassett |
Thermostable Vaccine Compositions and Methods of Preparing Same
|
|
EP3449938A1
(en)
|
2011-05-17 |
2019-03-06 |
Soligenix, Inc. |
Thermostable vaccine compositions and methods of preparing same
|
|
CN105797140B
(zh)
|
2011-06-17 |
2020-08-11 |
哈洛齐梅公司 |
乙酰透明质酸降解酶的稳定制剂
|
|
US8586020B2
(en)
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
US20130053792A1
(en)
|
2011-08-24 |
2013-02-28 |
Ablative Solutions, Inc. |
Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation
|
|
KR20130022923A
(ko)
|
2011-08-26 |
2013-03-07 |
삼성전자주식회사 |
가상 시점 합성 예측을 이용한 부호화/복호화 장치 및 부호화/복호화 방법
|
|
US9474689B2
(en)
|
2011-10-25 |
2016-10-25 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
|
MX363734B
(es)
|
2011-10-27 |
2019-03-29 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco.
|
|
US9283217B2
(en)
|
2011-11-10 |
2016-03-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
|
|
JP6095678B2
(ja)
|
2011-11-11 |
2017-03-15 |
エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド |
薬剤パッケージ用の不動態化、ｐＨ保護又は滑性皮膜、被覆プロセス及び装置
|
|
CA2858636C
(en)
|
2011-12-15 |
2022-01-18 |
Nestec S.A. |
Cohesive thin liquids to promote safe swallowing in dysphagic patients
|
|
US20140356340A1
(en)
|
2011-12-15 |
2014-12-04 |
Nestec S.A. |
Extensional viscosity to promote safe swallowing of food boluses
|
|
BR112014016195A2
(pt)
|
2011-12-30 |
2020-10-27 |
Halozyme, Inc. |
variantes de polipeptídio ph20, formulações e usos das mesmas
|
|
EP2634190A1
(en)
|
2012-03-01 |
2013-09-04 |
Lead Discovery Center GmbH |
Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors
|
|
CN104254612B
(zh)
|
2012-04-26 |
2018-06-01 |
安迪苏法国联合股份有限公司 |
一种2,4-二羟基丁酸的生产方法
|
|
WO2014005039A2
(en)
|
2012-06-29 |
2014-01-03 |
Cytosorbents Corporation |
Methods of using polymers
|
|
US20150297800A1
(en)
|
2012-07-03 |
2015-10-22 |
Sio2 Medical Products, Inc. |
SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS
|
|
CN106170582A
(zh)
|
2012-07-03 |
2016-11-30 |
Sio2医药产品公司 |
药物包装的SiOx 阻隔物和涂布方法
|
|
AU2013285355A1
(en)
|
2012-07-06 |
2015-01-29 |
Genmab B.V. |
Dimeric protein with triple mutations
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
ES2609654T3
(es)
|
2012-07-31 |
2017-04-21 |
Nestec S.A. |
Composición nutritiva para promover la salud del aparato locomotor de pacientes que sufren la enfermedad del intestino inflamatorio (IBD)
|
|
ES2750005T3
(es)
|
2012-08-05 |
2020-03-24 |
Absci Llc |
Sistema de coexpresión inducible
|
|
US10980865B2
(en)
|
2012-08-10 |
2021-04-20 |
Aquavit Pharmaceuticals, Inc. |
Direct application system and method for the delivery of bioactive compositions and formulations
|
|
US10894062B2
(en)
|
2012-08-10 |
2021-01-19 |
Aquavit Pharmaceuticals, Inc. |
Vitamin supplement compositions for injection
|
|
WO2015020982A2
(en)
|
2013-08-04 |
2015-02-12 |
Aquavit Pharmaceuticals, Inc. |
Direct application system and method for the delivery of bioactive compositions and formulations
|
|
FR2996855B1
(fr)
|
2012-10-16 |
2016-11-11 |
Lesaffre & Cie |
Souches de levures pour la production de biomasse sur un substrat comprenant un sucre en c5, leurs procedes d'obtention et utilisations de la biomasse produite
|
|
US20140120077A1
(en)
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and Methods for Safe Treatment of Rhinitis
|
|
GB201219602D0
(en)
|
2012-10-31 |
2012-12-12 |
Syntaxin Ltd |
Recombinant clostridium botulinum neurotoxins
|
|
CA2880897C
(en)
|
2012-11-21 |
2020-01-14 |
Ipsen Bioinnovation Limited |
Methods for the manufacture of proteolytically processed polypeptides
|
|
AU2013350328A1
(en)
|
2012-11-26 |
2015-07-09 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
|
TR201809679T4
(tr)
|
2012-12-28 |
2018-07-23 |
Cellestis Ltd |
Hücre aracılı bir immün yanıt tahlili.
|
|
MX369359B
(es)
|
2013-01-11 |
2019-11-06 |
Impossible Foods Inc |
Replica no lactea de queso ricotta.
|
|
WO2014124096A1
(en)
|
2013-02-06 |
2014-08-14 |
Perosphere Inc. |
Stable glucagon formulations
|
|
US9650608B2
(en)
|
2013-02-22 |
2017-05-16 |
Medivet America, Llc |
Activating adipose-derived stem cells for transplantation
|
|
EP2961858B1
(en)
|
2013-03-01 |
2022-09-07 |
Si02 Medical Products, Inc. |
Coated syringe.
|
|
CN110074968B
(zh)
|
2013-03-11 |
2021-12-21 |
Sio2医药产品公司 |
涂布包装材料
|
|
US9937099B2
(en)
|
2013-03-11 |
2018-04-10 |
Sio2 Medical Products, Inc. |
Trilayer coated pharmaceutical packaging with low oxygen transmission rate
|
|
EP3391898A3
(en)
|
2013-03-13 |
2019-02-13 |
President and Fellows of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
|
EP2986140A4
(en)
|
2013-03-15 |
2016-10-19 |
Nusirt Sciences Inc |
COMPOSITIONS, PROCESSES AND KIT FOR TREATMENT OF PETS
|
|
JP6538025B2
(ja)
|
2013-03-15 |
2019-07-03 |
リズム・ファーマシューティカルズ・インコーポレイテッド |
医薬組成物
|
|
US9603799B2
(en)
|
2013-03-15 |
2017-03-28 |
Htd Biosystems Inc. |
Liposomal vaccine adjuvants and methods of making and using same
|
|
CA2903752A1
(en)
|
2013-03-15 |
2014-09-25 |
Nusirt Sciences, Inc. |
Treatment of pets with sirtuin activators
|
|
JP2016516419A
(ja)
|
2013-03-26 |
2016-06-09 |
プレミア・ニュートリション・コーポレイション |
同時トレーニングに続いて筋タンパク質合成を高めるための方法
|
|
EP2981249A4
(en)
|
2013-04-02 |
2016-11-23 |
Stc Unm |
MESOPOROUS ALAN NANOPARTICLES AS A UNIVERSAL PLATFORM FOR ADSORPTION, PRESENTATION, AND ADMINISTRATION OF ANTIGENS
|
|
AU2013387115A1
(en)
|
2013-04-16 |
2015-11-05 |
Nestec S.A. |
Shelf-stable fermented dairy products and methods of making same
|
|
RU2535115C1
(ru)
|
2013-05-15 |
2014-12-10 |
Бости Трейдинг Лтд |
Фармацевтический состав, содержащий нейротоксин ботулина
|
|
WO2014186754A2
(en)
|
2013-05-16 |
2014-11-20 |
Board Of Regents The University Of Texas System |
Dry solid aluminum adjuvant-containing vaccines and related methods thereof
|
|
CN103257233B
(zh)
|
2013-05-31 |
2015-08-05 |
南京祥中生物科技有限公司 |
一种同时可视化检测多种抗生素、非法添加剂及生物毒素的生物芯片及方法
|
|
AU2014286177B2
(en)
|
2013-07-02 |
2018-01-18 |
Austrianova Singapore Pte Ltd. |
A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions
|
|
DK3033413T4
(da)
|
2013-08-15 |
2023-07-03 |
Lallemand Hungary Liquidity Man Llc |
Fremgangsmåder til forbedring af produktudbytte og produktion i en mikroorganisme gennem recirkulering af glycerol
|
|
US9480731B2
(en)
*
|
2013-12-12 |
2016-11-01 |
Medy-Tox, Inc. |
Long lasting effect of new botulinum toxin formulations
|
|
CN103705913A
(zh)
*
|
2013-12-27 |
2014-04-09 |
柳州市工人医院 |
A型肉毒毒素在制备治疗雷诺综合征药物的应用
|
|
WO2015103497A1
(en)
|
2014-01-02 |
2015-07-09 |
Trelys, Inc. |
Compositions and methods for biological production of amino acids in hydrogenotrophic microorganisms
|
|
US10260111B1
(en)
|
2014-01-20 |
2019-04-16 |
Brett Eric Etchebarne |
Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
|
|
CN106163526B
(zh)
|
2014-01-29 |
2021-07-23 |
维奥姆治疗有限公司 |
抗性痤疮的治疗
|
|
US20170007675A1
(en)
|
2014-02-06 |
2017-01-12 |
Xeris Pharmaceuticals, Inc. |
Stable peptide formulations and methods for preparation
|
|
EP3104868A2
(fr)
|
2014-02-14 |
2016-12-21 |
Vesale Pharma Sa |
Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
|
|
TW201613864A
(en)
|
2014-02-20 |
2016-04-16 |
Takeda Pharmaceutical |
Novel compounds
|
|
US9389162B2
(en)
|
2014-04-10 |
2016-07-12 |
City University Of Hong Kong |
Detection of analyte using coffee-ring effect
|
|
WO2015157595A1
(en)
|
2014-04-11 |
2015-10-15 |
Medimmune, Llc |
Conjugated compounds comprising cysteine-engineered antibodies
|
|
CA2945951A1
(en)
|
2014-04-15 |
2015-10-22 |
Industrial Microbes, Inc. |
Synthetic methanotrophic microorganisms
|
|
GB201407525D0
(en)
|
2014-04-29 |
2014-06-11 |
Syntaxin Ltd |
Manufacture of recombinant clostridium botulinum neurotoxins
|
|
DK3137053T3
(da)
*
|
2014-04-30 |
2020-09-07 |
Allergan Inc |
Formuleringer af biologiske lægemidler til intravesikal instillation
|
|
EP3149187B1
(en)
|
2014-05-30 |
2020-04-29 |
Braskem S.A. |
Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
|
|
US9901627B2
(en)
|
2014-07-18 |
2018-02-27 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
WO2016014750A1
(en)
|
2014-07-23 |
2016-01-28 |
Landy Toth |
Precision chemical ablation and treatment of tissues
|
|
CN107105749A
(zh)
|
2014-08-13 |
2017-08-29 |
阿克索生物医药公司 |
抗微生物化合物和组合物及其用途
|
|
WO2016029146A1
(en)
|
2014-08-22 |
2016-02-25 |
University Of Washington |
Specific inhibitors of methionyl-trna synthetase
|
|
US10729896B2
(en)
|
2014-09-23 |
2020-08-04 |
Avidas Pharmaceuticals Llc |
Delivery and induction of therapeutic agents and uses thereof
|
|
US10381112B2
(en)
|
2014-10-21 |
2019-08-13 |
uBiome, Inc. |
Method and system for characterizing allergy-related conditions associated with microorganisms
|
|
US10410749B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
|
|
US10325685B2
(en)
|
2014-10-21 |
2019-06-18 |
uBiome, Inc. |
Method and system for characterizing diet-related conditions
|
|
US9710606B2
(en)
|
2014-10-21 |
2017-07-18 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
|
US10366793B2
(en)
|
2014-10-21 |
2019-07-30 |
uBiome, Inc. |
Method and system for characterizing microorganism-related conditions
|
|
US10357157B2
(en)
|
2014-10-21 |
2019-07-23 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
|
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
BR102014028009B1
(pt)
|
2014-11-10 |
2023-04-18 |
Universidade Federal De Pelotas |
Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
|
|
GB201421013D0
(en)
|
2014-11-26 |
2015-01-07 |
Turzi Antoine |
New standardizations & medical devices for the preparation of platelet rich plasma (PRP) or bone marrow centrate (BMC)
|
|
EP3226849A4
(en)
|
2014-12-03 |
2018-05-09 |
Velicept Therapeutics, Inc. |
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
|
|
JP6821866B2
(ja)
|
2014-12-08 |
2021-01-27 |
ジェイワイエスケイ・スキン・ソリューションズ・プライベイト・リミテッドＪＹＳＫ Ｓｋｉｎ Ｓｏｌｕｔｉｏｎｓ Ｐｔｅ． Ｌｔｄ． |
担体分子組成物および関連方法
|
|
WO2016105510A2
(en)
|
2014-12-26 |
2016-06-30 |
Conjugon, Inc. |
Methods and compositions for growth, storage, and use of bacterial preparations for wound and surface treatments
|
|
US11040022B2
(en)
|
2015-02-05 |
2021-06-22 |
William H. Cross, III |
Compositions and methods for pain relief
|
|
BR112017019349A2
(pt)
|
2015-03-11 |
2018-06-05 |
Melinta Therapeutics Inc |
compostos antimicrobianos e métodos de fabricação e uso dos mesmos
|
|
CN107847533A
(zh)
|
2015-03-13 |
2018-03-27 |
进化生物系统股份有限公司 |
代谢或隔绝游离的糖单体的组合物及其应用
|
|
WO2016154112A1
(en)
|
2015-03-20 |
2016-09-29 |
Children's National Medical Center |
Generating virus or other antigen-specific t cells from a naive t cell population
|
|
WO2016164705A1
(en)
|
2015-04-10 |
2016-10-13 |
Omar Abdel-Rahman Ali |
Immune cell trapping devices and methods for making and using the same
|
|
RU2017134547A
(ru)
|
2015-04-23 |
2019-04-09 |
Калейдо Байосайенсиз, Инк. |
Регуляторы микробиома и соответствующие варианты их применения
|
|
CN107847611A
(zh)
|
2015-05-26 |
2018-03-27 |
阿德瓦希斯公司 |
个性化的基于递送载体的免疫疗法及其用途
|
|
WO2017027742A1
(en)
|
2015-08-11 |
2017-02-16 |
Akeso Biomedical, Inc. |
Biofilm inhibiting compositions enhancing weight gain in livestock
|
|
MA42667A
(fr)
|
2015-08-20 |
2021-05-05 |
Genomatica Inc |
Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser
|
|
WO2017051254A1
(en)
|
2015-09-25 |
2017-03-30 |
Legochem Biosciences, Inc. |
Compositions and methods related to anti-egfr antibody drug conjugates
|
|
US11185361B2
(en)
|
2015-10-12 |
2021-11-30 |
Landy Toth |
Controlled and precise treatment of cardiac tissues
|
|
CA3006242A1
(en)
|
2015-11-25 |
2017-06-01 |
Legochem Biosciences, Inc. |
Conjugates comprising self-immolative groups and methods related thereto
|
|
CA3006247A1
(en)
|
2015-11-25 |
2017-06-01 |
Legochem Biosciences, Inc. |
Conjugates comprising peptide groups and methods related thereto
|
|
EP3380126A4
(en)
|
2015-11-25 |
2019-07-24 |
LegoChem Biosciences, Inc. |
ANTIBODY-ACTIVE CONJUGATES WITH BRANCHED LINKERS AND ASSOCIATED METHODS
|
|
CN105363018B
(zh)
|
2015-12-02 |
2019-08-30 |
南京碧迪可医药科技有限公司 |
一种硫肽环素的新用途
|
|
WO2017123367A1
(en)
|
2016-01-11 |
2017-07-20 |
Siemens Aktiengesellschaft |
Program randomization for cyber-attack resilient control in programmable logic controllers
|
|
ES2862345T3
(es)
|
2016-01-21 |
2021-10-07 |
Selux Diagnostics Inc |
Métodos rápidos para probar la susceptibilidad antimicrobiana
|
|
US20170209553A1
(en)
|
2016-01-22 |
2017-07-27 |
Transderm, Inc. |
Delivery of botulinum with microneedle arrays
|
|
JP7007298B2
(ja)
|
2016-01-25 |
2022-02-10 |
バイオ―ラッド ヨーロッパ ゲーエムベーハー |
デジタル微生物学
|
|
US11771752B2
(en)
|
2016-03-09 |
2023-10-03 |
Prime Bio, Inc. |
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
|
|
WO2017161181A1
(en)
|
2016-03-16 |
2017-09-21 |
Spogen Biotech Inc. |
Fusion proteins, recombinant bacteria, and exosporium fragments for animal health and aquaculture
|
|
IL304057B2
(en)
|
2016-03-16 |
2025-03-01 |
Spogen Biotech Inc |
Methods for promoting plant health using free enzymes and microorganisms that cause enzyme overexpression
|
|
US20170290778A1
(en)
|
2016-04-12 |
2017-10-12 |
Illustris Pharmaceuticals, Inc. |
Compositions for topical application of compounds
|
|
WO2017179775A1
(en)
|
2016-04-12 |
2017-10-19 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
CA3022294A1
(en)
|
2016-04-25 |
2017-11-02 |
uBiome, Inc. |
Method and system for characterizing skin-related conditions
|
|
PT3463432T
(pt)
|
2016-05-27 |
2021-01-12 |
Ipsen Biopharm Ltd |
Formulação líquida de neurotoxina estabilizada com triptofano ou tirosina
|
|
US20170348263A1
(en)
|
2016-06-03 |
2017-12-07 |
Velicept Therapeutics, Inc. |
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
|
|
TWI737742B
(zh)
|
2016-06-22 |
2021-09-01 |
德商梅茲製藥有限兩合公司 |
肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用
|
|
EP3481851B1
(en)
|
2016-07-08 |
2021-11-24 |
Metabolic Explorer |
Method for the fermentative production of molecules of interest by microorganisms comprising genes coding sugar phosphotransferase system (pts)
|
|
WO2018038585A1
(ko)
|
2016-08-26 |
2018-03-01 |
주식회사 에이비바이오 |
보툴리눔 독소 및 안정화제를 포함하는 액상 제형 및 이의 제조방법
|
|
WO2018038301A1
(en)
|
2016-08-26 |
2018-03-01 |
Hugel Inc. |
Stabilized liquid formulation of botulinum toxin and preparation method thereof
|
|
EP3503877B8
(en)
|
2016-08-26 |
2022-04-20 |
SK Joint Ventures II, LLC |
Biodegradable polymer formulations for extended efficacy of botulinum toxin
|
|
US11554108B2
(en)
|
2016-08-29 |
2023-01-17 |
Xeropedix, Inc. |
Methods and compositions for treating cutaneous fungal infections
|
|
IL308091B1
(en)
|
2016-09-13 |
2026-01-01 |
Allergan Inc |
Protein-free stabilized Clostridium toxin preparations
|
|
KR102463881B1
(ko)
|
2016-10-04 |
2022-11-07 |
(주)메디톡스 |
보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
|
|
AU2017351950A1
(en)
|
2016-10-26 |
2019-05-02 |
Oxy Solutions As |
Formulations
|
|
WO2018083692A1
(en)
|
2016-11-01 |
2018-05-11 |
Tamar Levin |
Novel methods for modulating protein expression in microorganisms
|
|
CN116143678A
(zh)
|
2016-11-14 |
2023-05-23 |
杭州多禧生物科技有限公司 |
偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
|
|
US20180147357A1
(en)
|
2016-11-29 |
2018-05-31 |
Amir Marashi |
Delivery method for preparation and administration of pharmaceutical compositions
|
|
US11040090B2
(en)
|
2016-12-08 |
2021-06-22 |
Prime Bio, Inc |
Botulinum neurotoxin compositions
|
|
EP3768851A4
(en)
|
2016-12-15 |
2022-03-09 |
Psomagen, Inc. |
METHOD AND SYSTEM FOR CHARACTERIZING DIET-RELATED CONDITIONS
|
|
WO2018112138A1
(en)
|
2016-12-15 |
2018-06-21 |
Anavi Goffer Sharon |
Treatment of mental, movement and behavioral disorders
|
|
WO2018125891A1
(en)
|
2016-12-27 |
2018-07-05 |
IMB Inc. |
Processing human milk for generating compositions of fortified human milk products
|
|
CN108322936B
(zh)
|
2017-01-16 |
2023-06-02 |
中兴通讯股份有限公司 |
数据重传的方法及装置
|
|
EP3570682A4
(en)
|
2017-01-17 |
2021-03-03 |
White Dog Labs, Inc. |
PROTEINIC BIOMASS PREPARATION WITH A NON-NATIVE ORGANISM OF THE CLOSTRIDIA CLASS
|
|
US20200121739A1
(en)
|
2017-01-18 |
2020-04-23 |
Evelo Biosciences, Inc. |
Bacteria for treating cancer
|
|
KR101744900B1
(ko)
|
2017-01-20 |
2017-06-08 |
주식회사 대웅 |
보툴리눔 독소를 포함하는 안정한 액상 조성물
|
|
KR101776659B1
(ko)
|
2017-02-27 |
2017-09-11 |
주식회사 쿼드메디슨 |
마이크로 니들 및 이의 제조방법
|
|
WO2018175899A1
(en)
|
2017-03-24 |
2018-09-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Targeted nanogels for urinary bladder therapies
|
|
WO2018195097A1
(en)
|
2017-04-17 |
2018-10-25 |
The Regents Of The University Of California |
Engineered commensal bacteria and methods of use
|
|
JOP20190245A1
(ar)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
|
|
EP3622289B1
(de)
|
2017-05-11 |
2023-08-23 |
Immundiagnostik AG |
Verfahren und testbesteck zur quantitativen bestimmung von biomarkern in fäkalproben
|
|
CA3063542C
(en)
|
2017-05-24 |
2022-06-28 |
Sung Su Jang |
Pharmaceutical composition for treating foot pain disease including botulinum toxin and hyaluronic acid, and foot pain disease treatment method using same
|
|
EP3630298A1
(en)
|
2017-05-31 |
2020-04-08 |
Allergan, Inc. |
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
|
|
FR3067928B1
(fr)
|
2017-06-23 |
2020-02-28 |
Fondation Mediterranee Infection |
Procede de conservation d'un echantillon de bacteries
|
|
US20210145955A1
(en)
|
2017-06-26 |
2021-05-20 |
Bonti, Inc. |
Clostridial neurotoxin formulations and use
|
|
AU2018298087A1
(en)
|
2017-07-05 |
2020-01-23 |
Evelo Biosciences, Inc. |
Compositions and methods of treating cancer using bifidobacterium animalis ssp. lactis
|
|
CN111164706B
(zh)
|
2017-08-14 |
2024-01-16 |
普梭梅根公司 |
疾病相关的微生物组表征过程
|
|
WO2019046311A1
(en)
|
2017-08-28 |
2019-03-07 |
Revance Therapeutics, Inc. |
TRANSMUCOSAL COMPOSITIONS OF BOTULINUM TOXIN, KITS AND METHODS FOR TREATING BLADDER DISORDERS
|
|
EP3675883A4
(en)
|
2017-08-30 |
2021-05-12 |
Aobiome LLC |
MICROORGANISMS OXIDIZING AMMONIA FOR THE TREATMENT OF BUTTERFLY ERYTHEMA, ATHLETE'S FOOT, CONTACT DERMATITIS, SWEAT AND BODY ODORS
|
|
WO2019051204A1
(en)
|
2017-09-08 |
2019-03-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
SYNERGISTIC COMBINATION OF IL4, INTERFERON GAMMA AND INTERFERON ALPHA RECEPTOR AGENTS FOR USE IN THE TREATMENT OF OVARIAN CANCER
|
|
MX2020002659A
(es)
|
2017-09-08 |
2020-09-09 |
Evelo Biosciences Inc |
Vesiculas extracelulares bacterianas.
|
|
WO2019051381A1
(en)
|
2017-09-08 |
2019-03-14 |
Evelo Biosciences, Inc. |
EXTRACELLULAR VESICLES FROM PREVOTELLA
|
|
JP7792750B2
(ja)
|
2017-10-03 |
2025-12-26 |
クリティテック・インコーポレイテッド |
癌の治療のための免疫療法剤の全身送達と組み合わせた抗腫瘍粒子の局所送達
|
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
WO2019075452A1
(en)
|
2017-10-13 |
2019-04-18 |
Evelo Biosciences, Inc. |
IDENTIFICATION OF BACTERIA FOR CANCER THERAPY
|
|
JP2021502422A
(ja)
|
2017-11-13 |
2021-01-28 |
エクストレモチェム・エルディーエー．Ｅｘｔｒｅｍｏｃｈｅｍ，Ｌｄａ． |
生体分子の安定剤としての中性のグリコシル化されたアミド及びジアニオン性のグルクロン酸化された酸
|
|
JP2021502964A
(ja)
|
2017-11-14 |
2021-02-04 |
エヴェロ バイオサイエンシズ，インコーポレーテッド |
ブラウティア（Ｂｌａｕｔｉａ）株を使用して疾患を処置するための組成物及び方法
|
|
EP3713420A4
(en)
|
2017-11-22 |
2021-08-25 |
Aobiome LLC |
TOPICAL USE AND DELIVERY OF AMMONIA COXIDIZING MICRO-ORGANISMS
|
|
WO2019104136A1
(en)
|
2017-11-22 |
2019-05-31 |
Aobiome Llc |
Topical use and delivery of ammonia oxidizing microorganisms
|
|
CA3083953A1
(en)
|
2017-12-11 |
2019-06-20 |
Board Of Regents, The University Of Texas System |
Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
|
|
CN108205008B
(zh)
|
2017-12-28 |
2020-04-21 |
深圳大学 |
一种基于有机光电化学晶体管的毒素传感器及其制备方法
|
|
BR112020013872A2
(pt)
|
2018-01-07 |
2020-12-01 |
Avraham Amir |
microagulhas de alta carga e composições para aumento da pele
|
|
MY202181A
(en)
|
2018-01-24 |
2024-04-14 |
Omnigen Res Llc |
Bacillus combination for administration to animals
|
|
CN111712260A
(zh)
|
2018-01-31 |
2020-09-25 |
伊夫罗生物科学公司 |
使用毛螺菌科细菌治疗免疫病症的组合物和方法
|
|
CN112074283A
(zh)
|
2018-02-06 |
2020-12-11 |
伊夫罗生物科学公司 |
使用韦荣氏球菌属细菌治疗癌症和免疫病症的组合物和方法
|
|
CN112118849A
(zh)
|
2018-02-06 |
2020-12-22 |
瑞珍实验室 |
交联透明质酸及与prp/bmc的组合
|
|
KR102063475B1
(ko)
|
2018-02-22 |
2020-01-09 |
주식회사 에이비바이오 |
보툴리눔 독소, 안정화제, 및 국소마취제를 포함하는 액상 제형 및 이의 제조방법
|
|
WO2019166514A1
(en)
|
2018-02-28 |
2019-09-06 |
C-Lecta Gmbh |
Enzymatic in-situ fortification of food with functional carbohydrates
|
|
WO2019178055A1
(en)
|
2018-03-12 |
2019-09-19 |
Evelo Biosciences, Inc. |
Extracellular vesicles from burkholderia
|
|
WO2019174560A1
(zh)
|
2018-03-14 |
2019-09-19 |
必康生技（香港）有限公司 |
用于生物流体净化的组合物
|
|
EP3764988A4
(en)
|
2018-03-15 |
2022-04-20 |
Adepthera LLC |
GEL-FORMING POLYPEPTIDES
|
|
WO2019178487A2
(en)
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
|
|
WO2019178494A1
(en)
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions and methods for treating cancer and inflammation using tyzzerella nexilis
|
|
WO2019178490A1
(en)
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions and methods for treating cancer and inflammation using klebsiella oxytoca
|
|
US20190321427A1
(en)
|
2018-04-18 |
2019-10-24 |
G&S Laboratories, Inc. |
Compositions to Treat Anal Fissures
|
|
EP4295902A3
(en)
|
2018-05-03 |
2024-06-19 |
Crigasseni AG |
Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of clostridium difficile infection
|
|
WO2019226599A1
(en)
|
2018-05-22 |
2019-11-28 |
Alkalidx, Inc. |
Diagnostics and treatments of anesthetic insensitive subjects
|
|
US11464858B2
(en)
|
2018-06-23 |
2022-10-11 |
University Of Wyoming |
Magnetic nanoparticle delivery system for pain therapy
|
|
CN112888454A
(zh)
|
2018-09-13 |
2021-06-01 |
阿勒根公司 |
梭菌毒素-透明质酸组合物
|